1. Cell Therapy for Idiopathic Pulmonary Fibrosis: Rationale and Progress to Date

   • Paschalis Ntolios
   • Paschalis Steiropoulos
   • Argyrios Tzouvelekis

   Leading Article 07 September 2020 Pages: 543 - 556

2. Monoclonal Antibody-Based Therapies for Myasthenia Gravis

   • Sawsan Alabbad
   • Mohanad AlGaeed
   • Henry J. Kaminski

   Review Article 11 September 2020 Pages: 557 - 566

   

3. Designer Exosomes: A New Platform for Biotechnology Therapeutics

   • Davod Jafari
   • Samira Shajari
   • Ali Samadikuchaksaraei

   Review Article 04 August 2020 Pages: 567 - 586

   

4. Failed, Interrupted, or Inconclusive Trials on Immunomodulatory Treatment Strategies in Multiple Sclerosis: Update 2015–2020

   • Leoni Rolfes
   • Marc Pawlitzki
   • Sven G. Meuth

   Review Article Open access 12 August 2020 Pages: 587 - 610

   

5. Immunotherapy in Breast Cancer: Current Practice and Clinical Challenges

   • Debora de Melo Gagliato
   • Antonio C. Buzaid
   • Javier Cortes

   Review Article 01 September 2020 Pages: 611 - 623

6. Innovative Therapies for Hemoglobin Disorders

   • Karine Sii-Felice
   • Olivier Negre
   • Emmanuel Payen

   Review Article 08 September 2020 Pages: 625 - 647

   

7. Changes in Anthropometric Parameters After Anti-TNFα Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis

   • Faizan Mazhar
   • Vera Battini
   • Carla Carnovale

   Systematic Review Open access 17 September 2020 Pages: 649 - 668

   

8. Drug Survival of Biologics in Treating Ankylosing Spondylitis: A Systematic Review and Meta-analysis of Real-World Evidence

   • Chia-Ling Yu
   • Chung-Han Yang
   • Ching-Chi Chi

   Systematic Review 18 September 2020 Pages: 669 - 679

   

9. Efficacy and Safety of CT-P13 in Inflammatory Bowel Disease after Switching from Originator Infliximab: Exploratory Analyses from the NOR-SWITCH Main and Extension Trials

   • Kristin K. Jørgensen
   • Guro L. Goll
   • Jørgen Jahnsen

   Original Research Article Open access 23 September 2020 Pages: 681 - 694

   

10. PF-06410293: An Adalimumab Biosimilar

    • Arnold Lee
    • Matt Shirley

    Adis Biosimilar Brief 19 September 2020 Pages: 695 - 698

    

11. Correction to: Assessment of Structural and Functional Comparability of Biosimilar Products: Trastuzumab as a Case Study

    • Srishti Joshi
    • Anurag S. Rathore

    Correction 04 September 2020 Pages: 699 - 699